According to MarketsandMarkets™, the latest report, “ Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) – Global Forecast to 2030,” the global genomics market is projected to grow from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, registering a CAGR of 12.6% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613
Browse
- 671 Market Data Tables
- 68 Figures
- 560 Pages and in-depth TOC on “ Genomics Market – Global Forecast to 2030”.
What is fueling the rapid expansion of the genomics market, and why is it strategically important now?
Increasing investments in genomics research, the expansion of large-scale population genomics initiatives, and a growing focus on rare and genetic diseases are driving demand across healthcare and life sciences sectors. As stakeholders seek to improve patient outcomes, genomics is becoming central to enabling personalized and targeted therapies.
How are technological advancements transforming this market? Breakthroughs in next-generation sequencing (NGS) platforms, along with innovations in long-read sequencing (LRS), single-cell genomics, and CRISPR technologies, are significantly enhancing research capabilities. These technologies allow for deeper insights into genetic variations and disease mechanisms, enabling faster and more accurate diagnostics and therapeutic development.
Who is investing, and how does it impact the ecosystem? Leading pharmaceutical and biotechnology companies are significantly increasing investments in genomics-driven research, particularly in personalized medicine. By leveraging genomic insights, healthcare providers can better understand patient-specific needs and deliver tailored treatments, ultimately improving clinical outcomes and operational efficiency.
Why does the products segment dominate the market?
In 2024, the products segment accounted for the largest share of the genomics market. This dominance is driven by continuous innovation in genomics technologies, expanding product portfolios, and increasing demand for advanced tools and reagents that support complex genomic workflows across research and clinical applications.
What makes functional genomics a high-growth segment? Functional genomics is projected to register the highest CAGR through 2030, while also holding the largest share in 2024. Its critical role in identifying potential drug targets—particularly in oncology and genetic disorders—has made it indispensable for pharmaceutical research. Additionally, the biomarker discovery segment continues to hold the second-largest share, further highlighting the growing importance of data-driven insights in drug development.
Where are the most significant growth opportunities emerging?
The Asia Pacific region is expected to be the fastest-growing market during the forecast period. What is driving this regional momentum? Increasing government funding for genomic research, expanding healthcare infrastructure, and the rapid adoption of precision medicine initiatives across countries such as China, Japan, and India are key contributors. Furthermore, a large patient population and rising investments by both global and regional players are accelerating market expansion in the region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=613
Who are the key players shaping the competitive landscape?
Leading companies including Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, QIAGEN, Agilent Technologies, Inc., Revvity, Inc., Laboratory Corporation of America Holdings, IQVIA Inc., Charles River Laboratories, Bio-Rad Laboratories, Inc., Eurofins Scientific, PacBio, Oxford Nanopore Technologies Plc., Takara Bio Inc., BGI Group, Eppendorf SE, Merck KGaA, BD, Abbott, 10X Genomics, Inc., New England Biolabs, Promega Corporation, Creative Biogene, Novogene Co., Ltd., Helix, Inc., Phalanx Biotech Group, and Polaris Genomics are actively investing in innovation, strategic collaborations, and platform expansion to strengthen their market presence.
How will the competitive dynamics evolve? As genomics continues to intersect with artificial intelligence, bioinformatics, and precision medicine, companies that prioritize scalable technologies, data integration, and translational research capabilities are expected to gain a significant competitive advantage.
Related Reports:
CRISPR Market – Global Forecast to 2030
Next-generation Sequencing Market – Global Forecast to 2031
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html